Literature DB >> 28306694

Real-world use of ticagrelor and prasugrel in patients with NSTEMI undergoing percutaneous coronary intervention.

Vincenzo Sucato1, Egle Corrado, Carmelo Castellana, Michele Carella, Simona Raso, Giuseppe Coppola, Giuseppe Andolina, Giuseppina Novo, Salvatore Evola, Salvatore Novo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28306694     DOI： 10.2459/JCM.0000000000000516

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN： 1558-2027            Impact factor:   2.160


× No keyword cloud information.
  3 in total

1.  A Case of Ticagrelor Resistance.

Authors:  Jahanzeb Malik
Journal:  Eur J Case Rep Intern Med       Date:  2021-07-13

2.  Comparison of 4 different strategies of DAPT after PCI in ACS real world population from a Northern Italy registry.

Authors:  Marta Rasia; Emilia Solinas; Massimiliano Marino; Paolo Guastaroba; Alberto Menozzi; Maria Alberta Cattabiani; Iacopo Tadonio; Rossana De Palma; Luigi Vignali
Journal:  J Thromb Thrombolysis       Date:  2017-11       Impact factor: 2.300

Review 3.  Ticagrelor - toward more efficient platelet inhibition and beyond.

Authors:  Michał J Kubisa; Mateusz P Jezewski; Aleksandra Gasecka; Jolanta M Siller-Matula; Marek Postuła
Journal:  Ther Clin Risk Manag       Date:  2018-01-17       Impact factor: 2.423
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.